Acquisitions (Tables)

12 Months Ended

Dec. 31, 2013

Schedule Of Supplemental Pro Forma Results

Supplemental unaudited pro forma results for the years ended December 31, 2012 and 2011 are as follows:



(In Thousands, Except Per Share Data)	2012		2011
Sales	$	946,594	$	1,009,601
Income from continuing operations	44,816		43,407
Earnings per share from continuing operations:
Basic	$	1.40	$	1.36
Diluted	1.39		1.35

AACOA

Business Acquisition [Line Items]

Schedule Of Preliminary Estimated Purchase Price Allocation

Based upon management’s valuation of the fair value of tangible and intangible assets acquired (net of cash acquired) and liabilities assumed, the preliminary estimated purchase price allocation is as follows:



(In Thousands)
Accounts receivable	$	12,477
Inventories	4,708
Property, plant & equipment	15,116
Identifiable intangible assets:
Customer relationships	4,800
Trade names	4,800
Proprietary technology	3,400
Noncompete agreements	1,600
Other assets (current & noncurrent)	42
Trade payables & accrued expenses	(6,574		)
Total identifiable net assets	40,369
Purchase price, net of cash received	54,065
Goodwill	$	13,696

Schedule Of Amortized Periods For Acquired Intangible Assets

The goodwill and other intangible asset balances associated with this acquisition will be deductible for tax purposes. Intangible assets acquired in the purchase of AACOA are being amortized over the following periods:



Identifiable Intangible Asset	Useful Life (Yrs)
Customer relationships	10
Proprietary technology	6-10
Trade names	Indefinite
Noncompete agreements	2

Terphane

Business Acquisition [Line Items]

Schedule Of Preliminary Estimated Purchase Price Allocation

Based upon management’s valuation of the fair value of tangible and intangible assets acquired (net of cash acquired) and liabilities assumed, the final estimated purchase price allocation was as follows:



(In Thousands)
Accounts receivable	$	14,321
Inventories	23,437
Property, plant & equipment	86,963
Identifiable intangible assets:
Customer relationships	32,600
Proprietary technology	14,700
Trade names	9,400
Noncompete agreements	2,300
Other assets (current & noncurrent)	3,680
Trade payables	(17,471		)
Other liabilities (current & noncurrent)	(12,216		)
Deferred taxes	(38,167		)
Total identifiable net assets	119,547
Purchase price, net of cash received	182,761
Goodwill	$	63,214

Schedule Of Amortized Periods For Acquired Intangible Assets

None of the goodwill or other intangible assets will be deductible for tax purposes. Intangible assets acquired in the purchase of Terphane are being amortized over the following periods:



Identifiable Intangible Asset	Useful Life (Yrs)
Customer relationships	12
Proprietary technology	10
Trade names	Indefinite
Noncompete agreements	2